Articles dans des revues avec comité de lecture (25)
  1. 13. Kim, S. Y., Lee, J.-H., Merrins, M. M., Gavrilova, O., Bisteau, X., Kaldis, P., Satin, L. L., & Rane, S. S. (2017). Loss of Cyclin-dependent Kinase 2 in the Pancreas Links Primary β-Cell Dysfunction to Progressive Depletion of β-Cell Mass and Diabetes. The Journal of biological chemistry, 292(9), 3841-3853. doi:10.1074/jbc.M116.754077
  2. 14. Jayapal, S. R., Ang, H. Y.-K., Wang, C. Q., Bisteau, X., Caldez, M. M., Xuan, G. X., Yu, W., Tergaonkar, V., Osato, M., Lim, B., & Kaldis, P. (2016). Cyclin A2 regulates erythrocyte morphology and numbers. Cell cycle (Georgetown, Tex.), 15(22), 3070-3081. doi:10.1080/15384101.2016.1234546
  3. 15. Diril, K. M., Bisteau, X., Kitagawa, M., Caldez, M. M., Wee, S., Gunaratne, J., Lee, S. H., & Kaldis, P. (2016). Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint. PLOS genetics, 12(9), e1006310. doi:10.1371/journal.pgen.1006310
  4. 16. Chauhan, S., Diril, K. M., Lee, J. H. S., Bisteau, X., Manoharan, V., Adhikari, D., Ratnacaram, C. K., Janela, B., Noffke, J., Ginhoux, F., Coppola, V., Liu, K., Tessarollo, L., & Kaldis, P. (2016). Cdk2 catalytic activity is essential for meiotic cell division in vivo. Biochemical journal, 473(18), 2783-2798. doi:10.1042/BCJ20160607
  5. 17. Heijink, A. M., Blomen, V. V., Bisteau, X., Degener, F., Matsushita, F. Y., Kaldis, P., Foijer, F., & van Vugt, M. A. T. M. M. (2015). A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity. Proceedings of the National Academy of Sciences of the United States of America, 112(49), 15160-15165. doi:10.1073/pnas.1505283112
  6. 18. Jayapal, S. R., Wang, C. Q., Bisteau, X., Caldez, M. M., Lim, S., Tergaonkar, V., Osato, M., & Kaldis, P. (2015). Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress. Haematologica, 100(4), 431-438. doi:10.3324/haematol.2014.106468
  7. 19. Paternot, S., Colleoni, B., Bisteau, X., & Roger, P. P. (2014). The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes. Cell cycle, 13(18), 2879-2888. doi:10.4161/15384101.2014.946841
  8. 20. Bisteau, X., & Kaldis, P. (2014). Spy1/SpeedyA accelerates neuroblastoma. Oncotarget, 5(16), 6554-6555. doi:10.18632/oncotarget.2380
  9. 21. Bisteau, X., Caldez, M. M., & Kaldis, P. (2014). The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers (Basel), 6(1), 79-111. doi:10.3390/cancers6010079
  10. 22. Bisteau, X., Paternot, S., Colleoni, B., Ecker, K., Coulonval, K., De Groote, P., Declercq, W., Hengst, L., & Roger, P. P. (2013). CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. PLOS genetics, 9(5), e1003546. doi:10.1371/journal.pgen.1003546
  11. 23. Farhang Ghahremani, M., Goossens, S., Nittner, D., Bisteau, X., Bartunkova, S., Zwolinska, A., Hulpiau, P., Haigh, K., Haenebalcke, L., Drogat, B., Jochemsen, A., Roger, P. P., Marine, J.-C., & Haigh, J. J. (2013). p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell death and differentiation. doi:10.1038/cdd.2013.12
  12. 24. Paternot, S., Bockstaele, L., Bisteau, X., Kooken, H., Coulonval, K., & Roger, P. P. (2010). Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell cycle (Georgetown, Tex.), 9(4), 689-699.
    13. << Précédent 1 2 3 Suivant >>